Tag : FRACTIONAL FLOW RESERVE

CONFERENCE UPDATE

FFRangio demonstrates non-inferiority to pressure wire based physiologic assessment in intermediate coronary lesions: Results from the ALL-RISE randomized trial
The multicenter, randomized ALL-RISE trial demonstrated that angiography-derived fractional flow reserve (FFRangio)-guided revascularization for intermediate coronary lesions is non-inferior to conventional wire-based physiology. At 1 year, clinical outcomes (death, myocardial infarction, unplanned revascularization) were comparable and consistent across subgroups. Importantly, FFRangio significantly optimized procedural efficiency, reducing assessment time, fluoroscopy exposure, and overall duration.
NEWS AND PERSPECTIVE

Computational pressure-flow dynamics-derived FFR offers clinically meaningful and durable prognostic responses among patients with stable CAD
In the treatment of coronary artery disease (CAD), fractional flow reserve (FFR) can be performed during coronary angiography to evaluate the need for percutaneous coronary intervention (PCI).1 Nevertheless, the efficacy of wire-based FFR is constrained by its practical limitations.